ArrayExpress Uploaderarrayexpress_sid2513GS 8PSA 234ng/mlclinical T3aN1M0prostate cancer cellsGS 9PSA 80ng/mlclinical T3aN0M0prostate cancer cellsGS 9PSA 275ng/mlclinical T3bN0M0prostate cancer cellsGS 8PSA 1000ng/mlclinical T3bN1M1prostate cancer cellsGS 9PSA 311ng/mlclinical T4N1M1prostate cancer cellsGS 9PSA 334ng/mlclinical T3bN0M1prostate cancer cellsGS 9PSA 630ng/mlclinical T3aN0M1prostate cancer cellsGS 9PSA1900ng/mlclinical T2bN1M1prostate cancer cellsGS 9PSA 4427ng/mlclinical T4N1M1prostate cancer cellsGS 9PSA 5477ng/mlclinical T4N0M1prostate cancer cellsnot specifiednot specifiednot specifiednormal prostate (NP) epithelial cells04To identify molecules to serve as diagnostic markers for high-grade prostate cancer (PC) and targets for novel therapeutic drugs, we...19956859E-GEOD-45016/profile/8773/arrayexpressuploader411androgencancerprostateprostate cancerDec.12, 2014Falseexpression-data-from-high-grade-prostate-cancer-ceE-GEOD-45016_A-AFFY-44Expression data from High-grade prostate cancer cellsJul.12, 2014To identify molecules to serve as diagnostic markers for high-grade prostate cancer (PC) and targets for novel therapeutic drugs, we investigated the gene expression profiles of high-grade PCs using a cDNA microarray combined with laser microbeam microdissection. For this study, we collected 10 frozen specimens from high-grade PCs with high PSA levels and high Gleason score (GS) in clinically using prostatic needle biopsy. All needle biopsy specimens were at clinical stages T2 to T4 with or without N1 and M1 and their GS were 8-9. Moreover, all 10 patients had not received androgen ablation therapy. Simultaneously, normal prostate (NP) epithelial cells were also microdissected from five non-prostate cancer (BPH) patients. These NP cells from five males were used as a normal mixture control for our cDNA microarray analysis.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-45016humanhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-45016/samples/